EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017)

Cheng Xiao iD, Nancy H L Leung, Shiman Ling, Xia Lin, Yuyun Chen, Yanmin Xie, Malik Peiris, Mark Zanin, Benjamin Cowling iD, Sook-San Wong iD

Influenza and Other Respiratory Viruses · 2026-03 · 20 (3)

DOI: 10.1111/irv.70250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 13.03.2026. Verfasst von Cheng Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Re…. Hauptthemen laut MEDLINE: Immunoglobulin G, Antibodies, Viral. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong SAR Government, US Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The extent of cross‐reactive antibodies to SARS‐CoV‐2 elicited by seasonal human coronaviruses (HCoVs) remains unclear. We analyzed longitudinal preinfection and postinfection IgG responses in 62 older adults with PCR‐confirmed HCoV infections from sera collected prior to the emergence of SARS‐CoV‐2. At baseline, 12.9% and 16.1% had low‐titer antibodies against SARS‐CoV‐2 spike (S) or nucleocapsid (N) proteins, respectively, but postinfection increases were marginal. Our findings suggest seasonal HCoV infections induce limited SARS‐CoV‐2 cross‐reactive antibodies in community‐dwelling older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GAntibodies, ViralHumansAgedChinaSARS-CoV-2Cross ReactionsSeasonsFemaleMaleCOVID-19Spike Glycoprotein, CoronavirusPandemicsNucleocapsid ProteinsAged, 80 and over

Substanzen

Immunoglobulin GAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Nucleocapsid Proteins

Autor:innen und Institutionen

  • HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • State Key Laboratory for Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.
  • School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Center for Infection and Immunology, Hong Kong Science Park, Hong Kong Special Administrative Region, China.

ORCID-Profile: Cheng Xiao, Benjamin Cowling, Sook-San Wong

Förderung

  • Hong Kong SAR Government
  • US Centers for Disease Control and Prevention

Zitieren

APA

Xiao, C., Leung, N. H. L., Ling, S., Lin, X., Chen, Y., Xie, Y., Peiris, M., Zanin, M., Cowling, B., & Wong, S. S. (2026). Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017). Influenza and Other Respiratory Viruses, 20(3). https://doi.org/10.1111/irv.70250

Vancouver

Xiao C, Leung NHL, Ling S, Lin X, Chen Y, Xie Y, et al. Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017). Influenza and Other Respiratory Viruses. 2026;20(3). doi:10.1111/irv.70250

BibTeX
@article{Xiao2026,
  author = {Xiao, Cheng and Leung, Nancy H L and Ling, Shiman and Lin, Xia and Chen, Yuyun and Xie, Yanmin and Peiris, Malik and Zanin, Mark and Cowling, Benjamin and Wong, Sook-San},
  title = {Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017)},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  volume = {20},
  number = {3},
  doi = {10.1111/irv.70250}
}
Kostenlos starten →